David Melnick
2018
In 2018, David Melnick earned a total compensation of $1.6M as Chief Medical Officer at Spero Therapeutics.
Compensation breakdown
| Bonus | $10,000 |
|---|---|
| Non-Equity Incentive Plan | $146,300 |
| Option Awards | $1,082,146 |
| Salary | $375,680 |
| Other | $20,235 |
| Total | $1,634,361 |
Melnick received $1.1M in option awards, accounting for 66% of the total pay in 2018.
Melnick also received $10K in bonus, $146.3K in non-equity incentive plan, $375.7K in salary and $20.2K in other compensation.
Rankings
In 2018, David Melnick's compensation ranked 6,741st out of 14,244 executives tracked by ExecPay. In other words, Melnick earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,741 out of 14,244 | 53rd |
Division Manufacturing | 2,575 out of 5,765 | 55th |
Major group Chemicals And Allied Products | 966 out of 2,128 | 55th |
Industry group Drugs | 811 out of 1,817 | 55th |
Industry Pharmaceutical Preparations | 632 out of 1,391 | 55th |
Source: SEC filing on April 26, 2019.
Melnick's colleagues
We found three more compensation records of executives who worked with David Melnick at Spero Therapeutics in 2018.